연구성과로 돌아가기
JCR 2024 저널 목록 (780 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Journal of Sediment Research | KEAI PUBLISHING LTD | 1001-6279 | 2589-7284 | SCIE | ENVIRONMENTAL SCIENCES | 2,468 | 3.7 | Q2 | 39.4 | 60.6 | 148/374 | 3.8 | Q2 | 3.6 | 0.7 | 0.85 | 118/374 | Q2 | 68.58 | 0.002 | 0.388 | 0.679 | Q2 | 76 | 97.4% | 5.7 | 11.2 | 74 | 23.8% | 2025-08-05 16:03:13 | 바로가기 |
| Journal of Cancer | IVYSPRING INT PUBL | 1837-9664 | 1837-9664 | SCIE | ONCOLOGY | 13,674 | 3.2 | Q2 | 39.4 | 60.6 | 129/326 | 3.2 | Q2 | 3.1 | 0.8 | 0.72 | 133/326 | Q2 | 59.36 | 0.015 | 3.320 | 0.679 | Q3 | 532 | 92.5% | 4.9 | 5.8 | 492 | 97.4% | 2025-08-05 16:04:24 | 바로가기 |
| Journal of Immunotherapy and Precision Oncology | Innovative Healthcare Institute | 2666-2345 | 2590-017X | ESCI | ONCOLOGY | 233 | 3.2 | Q2 | 39.4 | 60.6 | 129/326 | N/A | N/A | 3.1 | 1.0 | 0.53 | 202/326 | Q3 | 38.19 | 0.001 | 0.128 | N/A | N/A | 31 | 64.5% | 2.6 | 6.5 | 20 | 89.9% | 2025-08-05 16:04:25 | 바로가기 |
| Journal of Marketing Analytics | PALGRAVE MACMILLAN LTD | 2050-3318 | 2050-3326 | ESCI | BUSINESS | 1,174 | 3.5 | Q2 | 39.4 | 60.6 | 125/316 | 5.0 | Q2 | 2.7 | 0.9 | 0.62 | 153/317 | Q2 | 51.89 | 0.001 | 0.245 | 0.711 | Q2 | 85 | 97.6% | 3.5 | 6.3 | 83 | 26.3% | 2025-08-05 16:02:36 | 바로가기 |
| Journal of Personal Selling & Sales Management | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 0885-3134 | 1557-7813 | ESCI | BUSINESS | 1,626 | 3.5 | Q2 | 39.4 | 60.6 | 125/316 | 4.1 | Q2 | 2.5 | 1.8 | 0.70 | 141/317 | Q2 | 55.68 | 0.001 | 0.221 | 0.992 | Q2 | 16 | 93.8% | 10.5 | 9.1 | 15 | 11.0% | 2025-08-05 16:02:36 | 바로가기 |
| JOURNAL OF PLANT RESEARCH | SPRINGER JAPAN KK | 0918-9440 | 1618-0860 | SCIE | PLANT SCIENCES | 3,856 | 2.3 | Q2 | 39.4 | 60.6 | 108/273 | 2.9 | Q2 | 2.3 | 0.5 | 0.75 | 85/275 | Q2 | 69.27 | 0.002 | 0.406 | 0.632 | Q2 | 92 | 100.0% | 9.2 | 11.8 | 92 | 21.8% | 2025-08-05 16:04:43 | 바로가기 |
| LAND DEGRADATION & DEVELOPMENT | WILEY | 1085-3278 | 1099-145X | SCIE | ENVIRONMENTAL SCIENCES | 13,489 | 3.7 | Q2 | 39.4 | 60.6 | 148/374 | 4.4 | Q2 | 3.4 | 0.7 | 0.80 | 130/374 | Q2 | 65.37 | 0.011 | 2.434 | 0.832 | Q2 | 413 | 95.4% | 5.2 | 6.3 | 394 | 10.6% | 2025-08-05 16:03:12 | 바로가기 |
| MOLECULAR CARCINOGENESIS | WILEY | 0899-1987 | 1098-2744 | SCIE | ONCOLOGY | 6,135 | 3.2 | Q2 | 39.4 | 60.6 | 129/326 | 3.5 | Q2 | 3.1 | 0.6 | 0.73 | 131/326 | Q2 | 59.97 | 0.004 | 0.866 | 0.751 | Q3 | 177 | 96.0% | 7.2 | 5.9 | 170 | 14.9% | 2025-08-05 16:04:24 | 바로가기 |
| NAR Cancer | OXFORD UNIV PRESS | 2632-8674 | 2632-8674 | ESCI | ONCOLOGY | 807 | 3.2 | Q2 | 39.4 | 60.6 | 129/326 | 3.9 | Q2 | 3.2 | 1.0 | 0.71 | 137/326 | Q2 | 58.13 | 0.002 | 0.518 | 1.518 | Q1 | 48 | 81.2% | 3.1 | 7.7 | 39 | 96.0% | 2025-08-05 16:04:25 | 바로가기 |
| NATURAL RESOURCES FORUM | WILEY | N/A | 1477-8947 | SCIE | ENVIRONMENTAL SCIENCES | 2,067 | 3.7 | Q2 | 39.4 | 60.6 | 148/374 | 4.2 | Q2 | 3.1 | 1.3 | 0.84 | 119/374 | Q2 | 68.32 | 0.001 | 0.196 | 0.564 | Q3 | 194 | 100.0% | 5.5 | 4.2 | 194 | 16.0% | 2025-08-05 16:03:13 | 바로가기 |
| Oncology and Therapy | SPRINGER | 2366-1070 | 2366-1089 | ESCI | ONCOLOGY | 621 | 3.2 | Q2 | 39.4 | 60.6 | 129/326 | 3.4 | Q2 | 3.1 | 0.6 | 0.56 | 194/326 | Q3 | 40.64 | 0.001 | 0.229 | 0.957 | Q2 | 53 | 81.1% | 3.5 | 5.0 | 43 | 100.0% | 2025-08-05 16:04:25 | 바로가기 |
| Plant Direct | JOHN WILEY & SONS LTD | N/A | 2475-4455 | SCIE | PLANT SCIENCES | 1,604 | 2.3 | Q2 | 39.4 | 60.6 | 108/273 | 2.9 | Q2 | 2.3 | 0.4 | 0.68 | 100/275 | Q2 | 63.82 | 0.003 | 0.564 | 0.720 | Q2 | 81 | 97.5% | 4.4 | 10.4 | 79 | 85.4% | 2025-08-05 16:04:44 | 바로가기 |
| Radiation Oncology | BMC | N/A | 1748-717X | SCIE | ONCOLOGY | 9,129 | 3.2 | Q2 | 39.4 | 60.6 | 129/326 | 3.8 | Q2 | 3.1 | 0.6 | 0.89 | 100/326 | Q2 | 69.48 | 0.009 | 2.036 | 1.010 | Q2 | 179 | 95.5% | 6.1 | 6.6 | 171 | 100.0% | 2025-08-05 16:04:24 | 바로가기 |
| SEMINARS IN RADIATION ONCOLOGY | W B SAUNDERS CO-ELSEVIER INC | 1053-4296 | 1532-9461 | SCIE | ONCOLOGY | 2,778 | 3.2 | Q2 | 39.4 | 60.6 | 129/326 | 4.6 | Q2 | 3.2 | 1.4 | 0.83 | 113/326 | Q2 | 65.49 | 0.002 | 0.507 | 1.330 | Q2 | 43 | 97.7% | 7.7 | 6.1 | 42 | 17.0% | 2025-08-05 16:04:25 | 바로가기 |
| Social Enterprise Journal | EMERALD GROUP PUBLISHING LTD | 1750-8614 | 1750-8533 | ESCI | BUSINESS | 1,035 | 3.5 | Q2 | 39.4 | 60.6 | 125/316 | 3.3 | Q3 | 2.8 | 0.3 | 0.60 | 159/317 | Q3 | 50.00 | 0.001 | 0.134 | 0.520 | Q3 | 61 | 96.7% | 6.3 | 7.8 | 59 | 11.6% | 2025-08-05 16:02:36 | 바로가기 |
페이지 이동: